Strategic Global Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,343
| Closed | -$510K | – | 147 |
|
|
2025
Q1 | $510K | Sell |
7,343
-161
| -2% | -$11.2K | 0.1% | 123 |
|
|
2024
Q4 | $645K | Sell |
7,504
-2,374
| -24% | -$204K | 0.12% | 109 |
|
|
2024
Q3 | $1.18M | Buy |
9,878
+3,879
| +65% | +$462K | 0.23% | 98 |
|
|
2024
Q2 | $1.6M | Sell |
5,999
-5,829
| -49% | -$1.56M | 0.34% | 80 |
|
|
2024
Q1 | $1.52M | Sell |
11,828
-106
| -0.9% | -$13.6K | 0.33% | 84 |
|
|
2023
Q4 | $1.23M | Sell |
11,934
-294
| -2% | -$30.4K | 0.28% | 98 |
|
|
2023
Q3 | $1.11M | Buy |
12,228
+332
| +3% | +$30.2K | 0.19% | 111 |
|
|
2023
Q2 | $963K | Buy |
11,896
+1,708
| +17% | +$138K | 0.15% | 111 |
|
|
2023
Q1 | $811K | Sell |
10,188
-204
| -2% | -$16.2K | 0.13% | 107 |
|
|
2022
Q4 | $703K | Sell |
10,392
-20
| -0.2% | -$1.35K | 0.11% | 105 |
|
|
2022
Q3 | $519K | Buy |
10,412
+488
| +5% | +$24.3K | 0.09% | 113 |
|
|
2022
Q2 | $553K | Buy |
+9,924
| New | +$553K | 0.08% | 117 |
|
|
2021
Q4 | – | Sell |
-17,022
| Closed | -$817K | – | 149 |
|
|
2021
Q3 | $817K | Sell |
17,022
-19,916
| -54% | -$956K | 0.12% | 129 |
|
|
2021
Q2 | $1.55M | Buy |
+36,938
| New | +$1.55M | 0.28% | 116 |
|
|
2016
Q2 | – | Sell |
-11,268
| Closed | -$305K | – | 151 |
|
|
2016
Q1 | $305K | Buy |
11,268
+2,260
| +25% | +$61.2K | 0.13% | 124 |
|
|
2015
Q4 | $262K | Hold |
9,008
| – | – | 0.11% | 122 |
|
|
2015
Q3 | $244K | Sell |
9,008
-3,416
| -27% | -$92.5K | 0.12% | 114 |
|
|
2015
Q2 | $340K | Buy |
+12,424
| New | +$340K | 0.2% | 107 |
|